<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" generatedBy="WIX">
<url>
<loc>https://www.tangramed.com/post/pxt3003-china-phase-3-cmt1a-results</loc>
<lastmod>2026-10-13</lastmod>
<image:image>
<image:loc>https://static.wixstatic.com/media/5a7ae0_80a13cff273546df85a6f5f188984474~mv2.png</image:loc>
<image:title>Illustration of a myelinated peripheral nerve accompanying the published Chinese Phase III PXT3003 results in Charcot-Marie-Tooth disease type 1A.</image:title>
</image:image>
</url>
<url>
<loc>https://www.tangramed.com/post/tangramed-biomunex-ai-oncology-collaboration</loc>
<lastmod>2026-10-13</lastmod>
<image:image>
<image:loc>https://static.wixstatic.com/media/5a7ae0_f7f93b9d8697443fa7625cac841b2b84~mv2.png</image:loc>
<image:title>Biomunex Pharmaceuticals and Tangramed Biotech research collaboration</image:title>
</image:image>
</url>
</urlset>